NHC
MRK icon

Nicholas Hoffman & Company’s Merck MRK Stock Holding History

Nicholas Hoffman & Company’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
14,754
-102
-0.7% -$11.8K 0.04% 93
2025
Q4 		$1.56M Sell
14,856
-1,345
-8% -$126K 0.04% 102
2025
Q3 		$1.36M Sell
16,201
-276
-2% -$22.7K 0.03% 106
2025
Q2 		$1.3M Buy
16,477
+114
+0.7% +$9.06K 0.03% 109
2025
Q1 		$1.47M Buy
16,363
+930
+6% +$86.8K 0.06% 95
2024
Q4 		$1.54M Buy
15,433
+365
+2% +$37.6K 0.06% 88
2024
Q3 		$1.71M Sell
15,068
-1,583
-10% -$188K 0.07% 77
2024
Q2 		$2.06M Buy
16,651
+164
+1% +$21.1K 0.1% 61
2024
Q1 		$2.18M Sell
16,487
-234
-1% -$28.8K 0.11% 62
2023
Q4 		$1.82M Sell
16,721
-187
-1% -$19.4K 0.11% 65
2023
Q3 		$1.74M Buy
16,908
+119
+0.7% +$12.8K 0.13% 68
2023
Q2 		$1.94M Sell
16,789
-225
-1% -$25.5K 0.08% 62
2023
Q1 		$1.81M Buy
17,014
+82
+0.5% +$8.85K 0.16% 66
2022
Q4 		$1.88M Buy
16,932
+6
+0% +$613 0.2% 60
2022
Q3 		$1.46M Sell
16,926
-223
-1% -$19.9K 0.07% 64
2022
Q2 		$1.56M Buy
17,149
+2,057
+14% +$182K 0.07% 66
2022
Q1 		$1.24M Buy
15,092
+243
+2% +$19.2K 0.05% 89
2021
Q4 		$1.14M Sell
14,849
-124
-0.8% -$9.88K 0.04% 95
2021
Q3 		$1.13M Sell
14,973
-964
-6% -$73.3K 0.2% 94
2021
Q2 		$1.24M Buy
15,937
+220
+1% +$16.4K 0.22% 86
2021
Q1 		$1.16M Buy
15,717
+421
+3% +$31.1K 0.23% 89
2020
Q4 		$1.19M Buy
15,296
+135
+0.9% +$10.3K 0.28% 67
2020
Q3 		$1.2M Buy
15,161
+137
+0.9% +$10.7K 0.32% 60
2020
Q2 		$1.11M Buy
15,024
+191
+1% +$14.4K 0.32% 62
2020
Q1 		$1.09M Buy
14,833
+656
+5% +$51.6K 0.37% 61
2019
Q4 		$1.23M Sell
14,177
-48
-0.3% -$3.94K 0.34% 65
2019
Q3 		$1.14M Sell
14,225
-597
-4% -$47.8K 0.35% 64
2019
Q2 		$1.19M Sell
14,822
-78
-0.5% -$5.97K 0.37% 63
2019
Q1 		$1.18M Buy
14,900
+206
+1% +$15.4K 0.38% 65
2018
Q4 		$1.07M Sell
14,694
-358
-2% -$25.3K 0.37% 62
2018
Q3 		$1.02M Buy
15,052
+714
+5% +$45.5K 0.34% 71
2018
Q2 		$830K Sell
14,338
-197
-1% -$11.1K 0.3% 79
2018
Q1 		$755K Buy
14,535
+379
+3% +$20.5K 0.29% 87
2017
Q4 		$760K Sell
14,156
-1,040
-7% -$57.7K 0.3% 85
2017
Q3 		$928K Sell
15,196
-87
-0.6% -$5.28K 0.39% 70
2017
Q2 		$935K Hold
15,283
– – 0.43% 67
2017
Q1 		$927K Buy
15,283
+27
+0.2% +$1.64K 0.43% 64
2016
Q4 		$876K Buy
15,256
+134
+0.9% +$7.84K 0.44% 61
2016
Q3 		$901K Buy
15,122
+1,428
+10% +$83.5K 0.49% 56
2016
Q2 		$753K Buy
+13,694
New +$729K 0.44% 61

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nicholas Hoffman & Company's MRK Position: Q1 2026 in Review

Nicholas Hoffman & Company reduced its Merck (MRK) stake by 0.69% in Q1 2026, selling an estimated $11.8K and leaving 14,754 shares worth $1.77M. The position accounts for 0.04% of the portfolio, ranked #93.

Nicholas Hoffman & Company first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.18M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Nicholas Hoffman & Company held 14,754 shares of Merck worth $1.77M as of Q1 2026.
  • Nicholas Hoffman & Company sold 102 Merck shares in Q1 2026, an estimated $11.8K.
  • Merck made up 0.04% of Nicholas Hoffman & Company's portfolio in Q1 2026, its #93 holding.
  • Nicholas Hoffman & Company first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
  • Nicholas Hoffman & Company's Merck position peaked at $2.18M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q1 2026, filed 29 Apr 2026.